ALFA Filings
Every announcement, straight from the exchange
Every Gland Pharma annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements with these filters
Gland Pharma issued a postal ballot notice to seek shareholder approval for appointing Mr. Xingli Wang as Non-Executive Director. E-voting runs October 7 to November 5, 2026.
Gland Pharma Limited held its 48th Annual General Meeting on August 25, 2026. The company provided its proceedings and the Chairman's speech.
Gland Pharma has issued a notice for its 48th Annual General Meeting to be held on August 25, 2026. The meeting agenda includes dividend declaration and director reappointments.
Gland Pharma Limited announced the results of the Postal Ballot, where all proposed resolutions regarding the appointment and remuneration of Independent Directors were passed.
Gland Pharma Limited announced the successful reappointment of Ms. Naina Lal Kidwai as an Independent Director through postal ballot. Shareholders approved the resolution with requisite majority.
Gland Pharma Limited clarified its postal ballot notice regarding Ms. Naina Lal Kidwai's reappointment. The company will obtain annual special resolutions from members if her remuneration exceeds 50% of the total Non-Executive Director pay for the FY 2026-2031 period.
Gland Pharma Limited has issued a postal ballot notice to shareholders for the re-appointment of Ms. Naina Lal Kidwai as an Independent Director. The special resolution also proposes commission on profits as remuneration. Voting will be conducted virtually from April 14, 2026, to May 13, 2026.
Gland Pharma Limited has issued a postal ballot notice seeking shareholder approval to reappoint Ms. Naina Lal Kidwai as an Independent Director for a second five-year term starting May 17, 2026. The resolution includes a proposed commission of 0.25% on net profits, capped at ₹1 Crore annually. Remote e-voting remains open from April 14 to May 13, 2026.